Search research articles
Contact Us
Filters
Showing results (1-10 of 109) with videos related to
Page
of 11
Sort By:
The Senior Care Pharmacist
|
December 2, 2022
Many People Take Proton Pump Inhibitor Unnecessarily: Reflecting On Why to Consider Deprescribing
Wade Thompson
African Journal of Primary Health Care & Family Medicine
|
January 23, 2025
Minimising harms of tight glycaemic control in older patients with type 2 diabetes
Wade Thompson
Basic & Clinical Pharmacology & Toxicology
|
November 20, 2023
Advancing deprescribing: Learnings from the first international conference on deprescribing
Carina Lundby, Wade Thompson
Research in Social & Administrative Pharmacy : RSAP
|
April 19, 2021
Deprescribing: Moving beyond barriers and facilitators
Wade Thompson, Emily Reeve
BMJ (Clinical Research Ed.)
|
January 21, 2026
Adverse effects of proton pump inhibitors
Wade Thompson, Anton Pottegård
The Canadian Journal of Hospital Pharmacy
|
July 2, 2013
Deprescribing: what is it and what does the evidence tell us?
Wade Thompson, Barbara Farrell
Annual Review of Medicine
|
September 20, 2023
Polypharmacy and Deprescribing in Older Adults
Wade Thompson, Emily G McDonald
Research in Social & Administrative Pharmacy : RSAP
|
May 26, 2021
Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
Frank Moriarty, Wade Thompson, Fiona Boland
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 23, 2013
Revisiting medication use in a frail 93-year-old man experiencing possible adverse effects
Barbara Farrell, Anne Monahan, Wade Thompson
European Journal of Internal Medicine
|
January 9, 2017
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action
Emily Reeve, Wade Thompson, Barbara Farrell
Page
of 11
Search research articles
Search
Showing results (1-10 of 109) with videos related to
Sort By:
Page
of 11
The Senior Care Pharmacist
|
December 2, 2022
Many People Take Proton Pump Inhibitor Unnecessarily: Reflecting On Why to Consider Deprescribing
Wade Thompson
African Journal of Primary Health Care & Family Medicine
|
January 23, 2025
Minimising harms of tight glycaemic control in older patients with type 2 diabetes
Wade Thompson
Basic & Clinical Pharmacology & Toxicology
|
November 20, 2023
Advancing deprescribing: Learnings from the first international conference on deprescribing
Carina Lundby, Wade Thompson
Research in Social & Administrative Pharmacy : RSAP
|
April 19, 2021
Deprescribing: Moving beyond barriers and facilitators
Wade Thompson, Emily Reeve
BMJ (Clinical Research Ed.)
|
January 21, 2026
Adverse effects of proton pump inhibitors
Wade Thompson, Anton Pottegård
The Canadian Journal of Hospital Pharmacy
|
July 2, 2013
Deprescribing: what is it and what does the evidence tell us?
Wade Thompson, Barbara Farrell
Annual Review of Medicine
|
September 20, 2023
Polypharmacy and Deprescribing in Older Adults
Wade Thompson, Emily G McDonald
Research in Social & Administrative Pharmacy : RSAP
|
May 26, 2021
Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
Frank Moriarty, Wade Thompson, Fiona Boland
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
October 23, 2013
Revisiting medication use in a frail 93-year-old man experiencing possible adverse effects
Barbara Farrell, Anne Monahan, Wade Thompson
European Journal of Internal Medicine
|
January 9, 2017
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action
Emily Reeve, Wade Thompson, Barbara Farrell
Page
of 11